Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid...

Ogkologos - 12 Αυγούστου, 2025

A Combination of Talazoparib and Enzalutamide Prolongs OS in Unselected and...

Ogkologos - 11 Αυγούστου, 2025

ESMO Recommendations on Cancer Care Reflected in Un ECOSOC Ministerial Declaration...

Ogkologos - 11 Αυγούστου, 2025

FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple...

Ogkologos - 8 Αυγούστου, 2025

EMA Recommends Extension of Therapeutic Indications for Darolutamide

Ogkologos - 7 Αυγούστου, 2025

Savolitinib Plus Osimertinib Show a High Response in EGFR-mutated NSCLC Progressed...

Ogkologos - 6 Αυγούστου, 2025

2025 ESMO Society Award recipients announced

Ogkologos - 5 Αυγούστου, 2025

Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ogkologos - 5 Αυγούστου, 2025

A Combination of Avutometinib Plus Defactinib Results in Clinically Meaningful Benefit...

Ogkologos - 5 Αυγούστου, 2025

OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally...

Ogkologos - 4 Αυγούστου, 2025

1...424344...440 Σελίδα 43 από 440

MOST POPULAR

Could Cholesterol-Lowering Drugs Improve Cancer Immunotherapy?

10 Δεκεμβρίου, 2020

FDA Approves Durvalumab for Muscle Invasive Bladder Cancer

2 Μαΐου, 2025

The Unique Challenges Teenagers and Young Adults With Cancer Face: An...

4 Ιανουαρίου, 2021

如何捐赠头发来帮助癌症患者

13 Απριλίου, 2022

Φόρτωση περισσοτέρων

Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid...

A Combination of Talazoparib and Enzalutamide Prolongs OS in Unselected and...

ESMO Recommendations on Cancer Care Reflected in Un ECOSOC Ministerial Declaration...

FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple...

EMA Recommends Extension of Therapeutic Indications for Darolutamide

Savolitinib Plus Osimertinib Show a High Response in EGFR-mutated NSCLC Progressed...

2025 ESMO Society Award recipients announced

Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

A Combination of Avutometinib Plus Defactinib Results in Clinically Meaningful Benefit...

OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally...

MOST POPULAR

Could Cholesterol-Lowering Drugs Improve Cancer Immunotherapy?

FDA Approves Durvalumab for Muscle Invasive Bladder Cancer

The Unique Challenges Teenagers and Young Adults With Cancer Face: An...

如何捐赠头发来帮助癌症患者

HOT NEWS

EMA Recommends Granting a Conditional Marketing Authorisation for Nogapendekin alfa Inbakicept

Woman with Nonverbal Autism Diagnosed with Breast Cancer After Caregiver Sister...

FDA Grants Regular Approval to Pembrolizumab and Lenvatinib for Advanced Endometrial...

Workout Wednesday – Upper Body Stretches

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ